Medicalia.org

by Internet Medical Society

Regorafenib: First Small-Molecule Multi-Kinase Inhibitor

Regorafenib falls under the category of drug class named multikinase inhibitors. It is used for Colorectal Cancer, Gastrointestinal Stromal Tumor, and Hepatocellular Carcinoma. The regorafenib cost is expected to fluctuate due to the availability of different brands. In order to know the cost of regorafenib, kindly dial our TOLL-FREE No: 1800-889-1064. Regorafenib is available as a tablet to administer by mouth. It is usually administered through a low-fat meal (containing under 600 calories and less than 30 percent of calories from fat) once daily for 21 days and then skipped for 7 days. This period of treatment is known as a cycle, and the cycle may be repeated for as long as your health specialist recommends.

Views: 1

Reply to This

Advertisement

Interested in advertising on Medicalia.org?

-------------------------

-------------------------

-------------------------

INTERNATIONAL ARCHIVES OF MEDICINE

Submit your manuscript

© 2022   Created by Network Admin.   Powered by

Badges  |  Report an Issue  |  Terms of Service